Moreover, GLP-1 receptors interact with various neurotransmitter systems such as serotonin, dopamine, and glutamate, which are essential for mood regulation and may contribute to the onset of depression and other psychological disorders [82]
Semaglutide led to a sustained, clinically relevant reduction in body weight in participants with obesity, offering a promising pharmacologic option for long-term weight management (Wilding, New England Journal of Medicine )
If youre wondering why the price of compounded semaglutide is often so different, the simple answer tends to be the provider offering itthey determine their cost based on their expenses
Preliminary results from this trial demonstrated promising improvements in disease activity, including reductions in lupus disease activity scores, improvement in inflammatory markers, and preservation of renal function in Semaglutide-treated patients compared to placebo
Bottom line Semaglutide is a GLP-1 medication, FDA-approved for chronic weight management in people with obesity and overweight
